Aquatic Capital Management LLC purchased a new position in shares of Northrop Grumman Corporation (NYSE: NOC) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,224 shares of the aerospace company's stock, valued at approximately $8,667,000. Several other hedge funds and
Game Creek Capital LP reduced its stake in shares of Northrop Grumman Corporation (NYSE: NOC) by 49.0% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 3,700 shares of the aerospace company's stock after selling 3,550 shares during the period. Game Creek Capital LP's holdings in
With three consecutive earnings beats after a $477M B-21 loss provision shook investor confidence, and now Northrop Grumman (NYSE:NOC) has a signed Air Force contract to back up what had been an earnings-call promise.
NOC wins a $225.1M Naval Air Systems Command contract to develop training materials for the E-130J program, boosting its position in the growing military training market.
Throughout the past year, Northrop Grumman (NOC) experienced modest revenue growth and a dip in margins, yet its stock skyrocketed by 63% as investor excitement drove a 59% increase in its P/E ratio. Strategic shifts—including converting a significant loss into growth in Aeronautics and achieving record backlog levels—propelled this impressive rise despite various challenges.
Northrop Grumman (NOC) reported earnings 30 days ago. What's next for the stock?
Northrop Grumman Corporation (NOC) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript
Northrop Grumman is rated Buy, leveraging unmatched vertical integration in solid rocket motors and a strategic deterrence duopoly with B-21 and Sentinel programs. NOC's industrial moat is deepened by tripling SRM capacity by 2027 and digital engineering, enabling margin expansion and decoupling growth from generic defense spending trends. Key risks include capital intensity, potential profitless growth from B-21 and Sentinel, and valuation-duration mismatch that may compress multiples if execution falters.
Northrop Grumman delivered double-digit Q4 sales growth and beat analyst estimates, reinforcing the strength of aerospace and defense investments. NOC's 2026 guidance is modest, with sales of $43.5–$44 billion, segment margins around 11%, and free cash flow growth remaining soft. I maintain a buy rating on NOC, targeting $745.16 per share, with 6% base-case upside and shareholder returns as a key appeal.
Northrop Grumman Corporation (NOC) Q4 2025 Earnings Call Transcript
NOC beats fourth-quarter earnings and revenue estimates as sales jump 9.6% year over year and backlog rises to $95.68 billion, led by strength across all four segments.
The headline numbers for Northrop Grumman (NOC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.